cancer therapy resistance
| 3 min read
An experimental drug significantly reduced tumor burden and extended survival in mice with pancreatic cancer.
Available on Demand
Antibodies that simultaneously target two distinct antigens overcome cancer therapy resistance by addressing antigenic diversity and diminished T cell action.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe